“By mapping the worldwide stress of drug-resistant bacteria and evaluating their impact on general public overall health, this listing is vital to guiding investment and grappling with the antibiotics pipeline and accessibility crisis," mentioned Dr Yukiko Nakatani, WHO’s Assistant Director-Basic for Antimicrobial Resistance ad interimDrug use